Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
EVMN
Evommune, Inc.
NYSE · Pharmaceutical Preparations
Last close
$8.26
· 2026-09-30
ABOUT
Exchange
NYSE
Sector
Healthcare
Industry
Pharmaceutical Preparations
Market cap
$299.77M
RECENT INSIDER TRADES
2026-07-10
· Carver Kyle
(Chief Financial Officer)
· BUY
2026-07-08
· KIRSCH ARTHUR S
(Director)
· BUY
2026-06-24
· Patel Jeegar Pravinkumar
(Chief Scientific Officer)
· SELL
2026-06-24
· Drew Janice Suzann
(Chief of Dev. Operations)
· SELL
2026-06-24
· Pena Luis C.
(President & CEO)
· SELL
INSTITUTIONAL OWNERSHIP
Institutional holders
110
Shares held
37,266,208
Value
$495.43M
Percent of shares outstanding
102.68%
As of quarter end
2026-06-30
RECENT NEWS
Evommune presents Phase 2a atopic dermatitis trial data
Evommune: Pipeline Reset After EVO756 Failure, All Eyes On EVO301
Cantor Fitzgerald reiterates Evommune stock rating at Overweight
Evommune (EVMN) Drops EVO756 for Eczema. Can EVO301 Carry the Pipeline?
Evommune, Inc. · 8-K (7.01,8.01,9.01)
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Evommune, Inc. (EVMN) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit